Keywords: lower-than-expected, losses, cat, signs, profit-sharing, deal, immunex

Lower-than-expected losses at CAT; signs profit-sharing deal with Immunex

Article | 23 May 2001

Cambridge Antibody Technologies of the UK has postednarrower-than-expected pretax losses of L924,000 ($1.3 million) for the six months ended March 31, 2001, down ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in